[ Price : $8.95]
CDER's Office of Prescription Drug Promotion sends an untitled letter to Edenbridge Pharmaceuticals over Hemady promotional materi...[ Price : $8.95]
FDA accepts for review a Corcept Therapeutics NDA for relacorilant and its use in treating patients with endogenous hypercortisoli...[ Price : $8.95]
Protagonist Therapeutics and Takeda report positive topline results for the Phase 3 VERIFY study that is evaluating rusfertide for...[ Price : $8.95]
Lexicon Pharmaceuticals says it will advance pain drug pilavapadin 10mg into a planned Phase 3 trial based on just-announced Phase...[ Price : $8.95]
PharmaTher also said it was working with its third-party manufacturing partner to resolve the deficiencies.[ Price : $8.95]
Boston Scientific recalls its Accolade pacemakers and Visionist and Valitude cardiac resynchronization therapy pacemakers due to t...[ Price : $8.95]
Philips recalls its Tack Endovascular Systems due to customer complaints, including events where additional interventions were req...[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America says FDA should make sure its recent draft guidance entitled Protocol Deviati...